$VCEL

SIEGAL JONATHAN sold $220K of VCEL

SIEGAL JONATHAN (Principal Accounting Officer) sold 4,500 shares of Vericel Corp (VCEL) at $48.90 ($0.22M total) across 3 trades on 2026-07-30 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · SIEGAL JONATHAN
Published Jul 31, 2026, 8:05 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 31, 2026, 8:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VCEL
Neutral
high confidence
Mentioned
$VCEL
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VCELNeutralLow
01

Why it matters

Because the transaction is explicitly tied to a 10b5-1 plan and contains no new business or regulatory updates, the incremental trading signal is mainly sentiment-related rather than fundamental.

02

Market read

Traders may note the disclosed insider sale size ($220,050) but should treat it as routine given the 10b5-1 context and lack of new fundamentals.

03

What to watch

The article does not indicate whether the sale was part of a larger scheduled program cadence, nor does it provide option exercises or purchases that could offset net insider activity.

Relevance 3/10Novelty 3/10Timing: filed 2026-07-31 after sale dated 2026-07-30

Background

The article is an SEC Form 4 insider transaction disclosure for Vericel Corp (VCEL) by an officer, including that it was executed under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$VCELNeutralHigh confidence
Context

Vericel Corp insider Form 4 shows principal accounting officer sold 4,500 shares at $48.90 on a 10b5-1 plan, totaling $220,050.

Expected impact

Low likelihood of a sustained price move; any reaction is likely short-lived and sentiment-driven.

Evidence & confidence

The filing is a disclosed open-market sale under a pre-arranged 10b5-1 plan, and the article provides no new company-specific developments beyond the transaction details.

Market effects

No sector read-through is provided; this is an isolated insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can be interpreted by some traders as confidence signaling, potentially creating short-term negative sentiment.

Key entities

  • Vericel Corp

    VCEL, subject of the Form 4 insider sale disclosure.

  • SIEGAL JONATHAN

    Principal Accounting Officer who sold 4,500 shares across three trades.

  • 10b5-1 plan

    Pre-arranged plan stated as Yes in the filing, reducing interpretive weight of the sale.

Related articles

$VCELMedAI 8/10

Vericel Q2 Earnings Call Highlights

Vericel (NASDAQ: VCEL) reported Q2 earnings call updates. Burn Care revenue rose 22% to about $12M, with Epicel at $10.4M and NexoBrid above $1.5M. 2026 guidance was raised to $330M-$340M total revenue, MACI to $284M-$290M, Burn Care to $46M-$50M, and Q3 revenue to $76.5M-$78.5M. Board authorized a $200M buyback.

$VCELHigh

Vericel Corp (VCEL): Results of Operations and Financial Condition

Vericel Corp (VCEL) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex991earningsreleaseq22026.htm EX-99.1 Document Exhibit 99.1 Vericel Corporation 25 Blue Sky Drive Burlington, MA 01803 T 617 588-5555 F 617 588-5554 www.vcel.com Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Sh